Journal of Clinical Medicine 2024 Feb 14;13(4):1079. doi: 10.3390/jcm13041079. Philippe Rigoard, Maxime Billot, Renaud Bougeard, Jose Emilio Llopis, Sylvie Raoul, Georgios Matis, Jan Vesper, Hayat Belaïd Abstract Spinal cord stimulation (SCS) is proven to effectively relieve chronic neuropathic pain. However, some implanted patients may face loss of efficacy
Examining the Type, Quality, and Content of Web-Based Information for People With Chronic Pain Interested in Spinal Cord Stimulation: Social Listening Study
Journal of Medical Internet Research 2024 Jan 30:26:e48599. doi: 10.2196/48599. Maarten Moens, Leen Van Doorslaer, Maxime Billot, Edgard Eeckman, Manuel Roulaud, Philippe Rigoard, Maaike Fobelets, Lisa Goudman Abstract Background: The increased availability of web-based medical information has encouraged patients with chronic pain to seek health care information from
Gut dysbiosis in patients with chronic pain: a systematic review and meta-analysis
Frontiers in immunology 2024 Jan 30:15:1342833. doi: 10.3389/fimmu.2024.1342833. eCollection 2024. Lisa Goudman, Thomas Demuyser, Julie G Pilitsis, Maxime Billot, Manuel Roulaud, Philippe Rigoard, Maarten Moens Abstract Introduction: Recent evidence supports the contribution of gut microbiota dysbiosis to the pathophysiology of rheumatic diseases, neuropathic pain, and neurodegenerative disorders. The
Is Spinal Cord Stimulation Still Effective After One or More Surgical Revisions?
Neuromodulation 2023 Jul;26(5):1102-1108.doi: 10.1016/j.neurom.2023.03.009. Epub 2023 Apr 19. Aurelie Leplus, Jimmy Voirin, Emmanuel Cuny, Marie Onno, Maxime Billot, Philippe Rigoard, Denys Fontaine Abstract Objectives: Spinal cord stimulation (SCS) is burdened with surgical complications that may require one or several surgical revision(s), challenging its risk/benefit ratio and